Literature DB >> 32723759

Multimodality imaging assessment of mitral annular disjunction in mitral valve prolapse.

Valentina Mantegazza1, Valentina Volpato2, Paola Gripari2, Sarah Ghulam Ali2, Laura Fusini2, Gianpiero Italiano2, Manuela Muratori2, Gianluca Pontone2, Gloria Tamborini2, Mauro Pepi2.   

Abstract

OBJECTIVE: Mitral annular disjunction (MAD) is an abnormality linked to mitral valve prolapse (MVP), possibly associated with malignant ventricular arrhythmias. We assessed the agreement among different imaging techniques for MAD identification and measurement.
METHODS: 131 patients with MVP and significant mitral regurgitation undergoing transthoracic echocardiography (TTE) and cardiac magnetic resonance (CMR) were retrospectively enrolled. Transoesophageal echocardiography (TOE) was available in 106 patients. MAD was evaluated in standard long-axis views (four-chamber, two-chamber, three-chamber) by each technique.
RESULTS: Considering any-length MAD, MAD prevalence was 17.3%, 25.5%, 42.0% by TTE, TOE and CMR, respectively (p<0.05). The agreement on MAD identification was moderate between TTE and CMR (κ=0.54, 95% CI 0.49 to 0.59) and good between TOE and CMR (κ=0.79, 95% CI 0.74 to 0.84). Assuming CMR as reference and according to different cut-off values for MAD (≥2 mm, ≥4 mm, ≥6 mm), specificity (95% CI) of TTE and TOE was 99.6 (99.0 to 100.0)% and 98.7 (97.4 to 100.0)%; 99.3 (98.4 to 100.0)% and 97.6 (95.8 to 99.4)%; 97.8 (96.2 to 99.3)% and 93.2 (90.3 to 96.1)%, respectively; sensitivity (95% CI) was 43.1 (37.8 to 48.4)% and 74.5 (69.4 to 79.5)%; 54.0 (48.7 to 59.3)% and 88.9 (85.2 to 92.5)%; 88.0 (84.5 to 91.5)% and 100.0 (100.0 to 100.0)%, respectively. MAD length was 8.0 (7.0-10.0), 7.0 (5.0-8.0], 5.0 (4.0-7.0) mm, respectively by TTE, TOE and CMR. Agreement on MAD measurement was moderate between TTE and CMR (ρ=0.73) and strong between TOE and CMR (ρ=0.86).
CONCLUSIONS: An integrated imaging approach could be necessary for a comprehensive assessment of patients with MVP and symptoms suggestive for arrhythmias. If echocardiography is fundamental for the anatomic and haemodynamic characterisation of the MV disease, CMR may better identify small length MAD as well as myocardial fibrosis. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cardiac magnetic resonance (CMR) imaging; echocardiography; mitral regurgitation

Year:  2020        PMID: 32723759     DOI: 10.1136/heartjnl-2020-317330

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  12 in total

1.  Malignant Mitral Valve Prolapse: Risk and Prevention of Sudden Cardiac Death.

Authors:  Yasufumi Nagata; Philippe B Bertrand; Robert A Levine
Journal:  Curr Treat Options Cardiovasc Med       Date:  2022-03-22

2.  Echocardiographic description and outcomes in a heterogeneous cohort of patients undergoing mitral valve surgery with and without mitral annular disjunction: a health service evaluation.

Authors:  Sadie Bennett; Jacopo Tafuro; Marcus Brumpton; Caragh Bardolia; Grant Heatlie; Simon Duckett; Paul Ridley; Prakash Nanjaiah; Chun Shing Kwok
Journal:  Echo Res Pract       Date:  2022-07-13

Review 3.  Mitral Valve Prolapse, Arrhythmias, and Sudden Cardiac Death: The Role of Multimodality Imaging to Detect High-Risk Features.

Authors:  Anna Giulia Pavon; Pierre Monney; Juerg Schwitter
Journal:  Diagnostics (Basel)       Date:  2021-04-10

Review 4.  Myxomatous Mitral Valve Disease with Mitral Valve Prolapse and Mitral Annular Disjunction: Clinical and Functional Significance of the Coincidence.

Authors:  Nina C Wunderlich; Siew Yen Ho; Nir Flint; Robert J Siegel
Journal:  J Cardiovasc Dev Dis       Date:  2021-01-24

Review 5.  Arrhythmic Mitral Valve Prolapse and Mitral Annular Disjunction: Clinical Features, Pathophysiology, Risk Stratification, and Management.

Authors:  Apurba K Chakrabarti; Frank Bogun; Jackson J Liang
Journal:  J Cardiovasc Dev Dis       Date:  2022-02-16

6.  Reply from authors: Many roads lead to Rome.

Authors:  Aniek L Wijngaarden; Anton Tomšič; Nina Ajmone Marsan; Meindert Palmen
Journal:  JTCVS Open       Date:  2021-08-05

7.  Association of Mitral Annular Disjunction With Cardiovascular Outcomes Among Patients With Marfan Syndrome.

Authors:  Anthony Demolder; Frank Timmermans; Mattias Duytschaever; Laura Muiño-Mosquera; Julie De Backer
Journal:  JAMA Cardiol       Date:  2021-10-01       Impact factor: 30.154

Review 8.  Arrhythmic Mitral Valve Prolapse: Introducing an Era of Multimodality Imaging-Based Diagnosis and Risk Stratification.

Authors:  Deni Kukavica; Marco Guglielmo; Andrea Baggiano; Giuseppe Muscogiuri; Laura Fusini; Manuela Muratori; Gloria Tamborini; Valentina Mantegazza; Alessandro Trancuccio; Carlo Arnò; Andrea Mazzanti; Mauro Pepi; Silvia Giuliana Priori; Gianluca Pontone
Journal:  Diagnostics (Basel)       Date:  2021-03-08

Review 9.  Diagnosis of Mitral Valve Prolapse: Much More than Simple Prolapse. Multimodality Approach to Risk Stratification and Therapeutic Management.

Authors:  Ali Alenazy; Abdalla Eltayeb; Muteb K Alotaibi; Muhammah Kashif Anwar; Norah Mulafikh; Mohammed Aladmawi; Olga Vriz
Journal:  J Clin Med       Date:  2022-01-17       Impact factor: 4.241

10.  Does Anatomic Phenotype of Mitral Annular Disjunction Impact Survival? An Autopsy-Based Retrospective Study.

Authors:  Nan Zhou; Qianhao Zhao; Rui Li; Da Zheng; Yuxi Xiao; Danmi Mao; Yunyi Wang; Jiacheng Yue; Kai Zhang; Jonathan C Makielski; Jianding Cheng
Journal:  J Cardiovasc Dev Dis       Date:  2021-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.